Skip to main content
OpenTrials
Completed

NCT Number: NCT03567070

Pregnancy and Use of Psychoactive Substances: The Influence of Representations of Care on Care.

It is observed that pregnant women using psychoactive substance (s) have a more random and more accidental pregnancy follow-up than women with no addictive problems.

The consumption approach can be either omitted during the pregnancy monitoring, or entrusted to the course or more often in late pregnancy or occurs more brutally during delivery at the time of complications (neonatal or obstetric). In this context, health professionals are looking for levers that allow women to take appropriate care quickly.

This difficulty of access to care questions us and all the more because the time of the pregnancy is a moment of important psychic reorganization conducive to modify its habits, to change its glance on its consumptions and thus to start a care concerning addiction.

Invesigators hypothesize that this population has less access to medical care during pregnancy for fear of stigmatization by the health care provider.

Invesigators propose a multicenter qualitative study based on individual clinical interviews to collect the testimony of women who used psychoactive substance (s) during their pregnancy.

The purpose of this work is to identify ways to improve the multidisciplinary medical management of these women by focusing on the representations they can make care of.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Caen University Hospital

Caen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major patients
  • Pregnant or having given birth since <28 days
  • Having used (whether declared or discovered incidentally) - regardless of the amount of psychoactive substance (s) during pregnancy: alcohol, and / or heroin or OST, and / or cannabis, and / or psychostimulants (cocaine, ecstasy, amphetamines)
  • Followed or not in addictology during pregnancy

Exclusion criteria

  • Minor patients
  • Patients under legal protection (guardianship, guardianship)
  • Linguistic obstacle
  • Psychiatric pathology decompensated at the time of the meeting
  • Women who only used tobacco regularly during pregnancy
  • Women who have only regularly used psychoactive drugs and / or licit opiates (excluding prescription replacement products) during pregnancy

Treatment and study plan

qualitative study based on an individual clinical interview

Other

qualitative study based on an individual clinical interview

Primary outcomes

  1. individual clinical interview

    Time frame: baseline

    qualitative study based on an individual clinical interview

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Acronym: ADDGEST

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Jun 25, 2018
Registry last updated
Jun 25, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.